| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.8 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.03 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |